Abstract
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical, and oncologic factors to the presence of elevated AFP levels in large cohort of patients with HCC.
| Original language | English |
|---|---|
| Pages (from-to) | 2150-2157 |
| Number of pages | 8 |
| Journal | Cancer |
| Volume | 120 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research
Keywords
- Adult
- Aged
- Alanine Transaminase
- Bilirubin
- Biological
- Carcinoma
- Cohort Studies
- Female
- Hepatitis C
- Hepatocellular
- Humans
- Italy
- Liver Cirrhosis
- Liver Function Tests
- Liver Neoplasms
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Serum Albumin
- Sex Factors
- Tumor Markers
- alanine aminotransferase
- alpha-Fetoproteins
- cirrhosis
- female
- oncology
Fingerprint
Dive into the research topics of 'Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver